Eagle Bay Advisors’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,138
Closed -$105K 459
2024
Q4
$105K Sell
1,138
-100
-8% -$9K 0.07% 200
2024
Q3
$104K Hold
1,238
0.04% 280
2024
Q2
$84.9K Sell
1,238
-156
-11% -$10.4K 0.05% 257
2024
Q1
$102K Buy
1,394
+28
+2% +$2.15K 0.06% 205
2023
Q4
$111K Sell
1,366
-232
-15% -$18.1K 0.07% 196
2023
Q3
$120K Buy
1,598
+219
+16% +$16.8K 0.06% 215
2023
Q2
$106K Sell
1,379
-80
-5% -$6.38K 0.06% 208
2023
Q1
$121K Sell
1,459
-187
-11% -$15.5K 0.07% 198
2022
Q4
$141K Buy
1,646
+241
+17% +$19.1K 0.08% 175
2022
Q3
$87K Buy
1,405
+313
+29% +$19.7K 0.05% 227
2022
Q2
$67.5K Buy
1,092
+731
+202% +$45.3K 0.04% 293
2022
Q1
$21K Sell
361
-827
-70% -$52.9K 0.02% 228
2021
Q4
$86K Sell
1,188
-858
-42% -$59.1K 0.05% 219
2021
Q3
$142K Buy
2,046
+1,209
+144% +$84.9K 0.08% 171
2021
Q2
$59K Buy
+837
New +$55.9K 0.05% 282

Other funds holding GILD

Eagle Bay Advisors's GILD Position: Q1 2025 in Review

Eagle Bay Advisors sold out of Gilead Sciences (GILD) in Q1 2025, closing a stake of 1,138 shares — an estimated $105K sold.

Eagle Bay Advisors first reported a position in GILD in Q2 2021 and held it in 15 quarters. The position peaked at $142K in Q3 2021. 2,013 funds tracked by Wall St. Rank hold GILD as of Q1 2025.

  • Eagle Bay Advisors reported no remaining Gilead Sciences position as of Q1 2025 after selling out during the quarter.
  • Eagle Bay Advisors sold 1,138 Gilead Sciences shares in Q1 2025, an estimated $105K.
  • Eagle Bay Advisors first reported a position in Gilead Sciences in Q2 2021 and held it in 15 quarters.
  • Eagle Bay Advisors's Gilead Sciences position peaked at $142K in Q3 2021.
  • 2,013 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2025.

Based on Eagle Bay Advisors's 13F filing for Q1 2025, filed 5 May 2025.